Not an expert, not a researcher, but an economist...
Not an expert, not a researcher, but an economist...
Was that worry all for nothing? Was it backed up by any science? If there was legitimate reason for concern, why do we not have the same concern around the j&j vaccine?
(I'm not trying to advocate any of these points. I'm even less qualified than an economist. But they seem like legitimate questions)
I believe it was because of a lack of evidence either way. The Pfizer trials were two doses. So we didn't know for sure how well one would work. The decision to only do one was made on the basis that this works well for most (but not all) vaccines. It is now known that it indeed works for the Pfizer vaccine, and so it seems to have been a good decision. The concern was that it would not and would set the vaccination programme back by months.
> Why do we not have the same concern around the j&j vaccine?
I'm not sure, but I suspect the J&J vaccine was trialed as one dose from the outset.
The most compelling J&J number is, IMHO, the 100% efficacy at preventing hospitalizations and deaths. Is a single shot of the double-shot vaccines that effective? AFAIK that study was never run..
We have a small sample for the estimate of this efficacy. That being said, all the vaccines have shown this in small samples, so my current working theory is that the hospitalisation rates post vaccine will be very, very low (but almost certainly not 0%).
This is more about looking at the ability of our systems to change their response in emergencies; why are obvious things so hard to do, when they both fully make sense, and are supported by an interested group of experts, against a larger but less interested group of conventional, rule-following experts?
I'm not saying all rejection of convention is correct, obviously - but if you look at the specifics of the argument, not the status or credentials of the arguer, it seems more likely to come to a correct judgement.